ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,052,000 | +53.1% | 32,837 | -1.9% | 0.02% | +36.4% |
| Q3 2021 | $1,993,000 | -14.7% | 33,471 | -2.3% | 0.01% | +37.5% |
| Q2 2021 | $2,337,000 | -0.6% | 34,266 | +1.1% | 0.01% | 0.0% |
| Q1 2021 | $2,352,000 | -9.4% | 33,889 | +0.3% | 0.01% | -20.0% |
| Q4 2020 | $2,597,000 | -0.1% | 33,799 | -2.8% | 0.01% | -16.7% |
| Q3 2020 | $2,600,000 | +19.9% | 34,769 | +0.9% | 0.01% | +20.0% |
| Q2 2020 | $2,168,000 | +72.6% | 34,443 | +15.2% | 0.01% | +42.9% |
| Q1 2020 | $1,256,000 | -12.5% | 29,897 | -5.5% | 0.01% | +16.7% |
| Q4 2019 | $1,436,000 | -0.6% | 31,625 | +0.2% | 0.01% | 0.0% |
| Q3 2019 | $1,444,000 | -22.5% | 31,548 | -0.7% | 0.01% | -14.3% |
| Q2 2019 | $1,863,000 | +31.3% | 31,769 | +0.4% | 0.01% | +40.0% |
| Q1 2019 | $1,419,000 | +11.5% | 31,655 | -3.1% | 0.01% | 0.0% |
| Q4 2018 | $1,273,000 | -16.0% | 32,683 | -0.8% | 0.01% | 0.0% |
| Q3 2018 | $1,516,000 | +7.5% | 32,933 | +1.8% | 0.01% | 0.0% |
| Q2 2018 | $1,410,000 | +16.3% | 32,340 | +5.4% | 0.01% | +25.0% |
| Q1 2018 | $1,212,000 | +34.7% | 30,671 | +15.8% | 0.00% | +33.3% |
| Q4 2017 | $900,000 | +35.3% | 26,487 | +1.6% | 0.00% | +50.0% |
| Q3 2017 | $665,000 | +98.5% | 26,081 | +31.2% | 0.00% | +100.0% |
| Q2 2017 | $335,000 | – | 19,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |